Amend 007 - DISO Adenovirus - Teva Pharmaceuticals USA Inc

Status Expired

Contract number W6369-19A009/001/PH

Solicitation number W6369-19A009/A

Publication date

Contract award date

Last amendment date

Contract value

CAD 0.00
Description

This contract was awarded to:

Teva Pharmaceuticals USA, Inc.
Adenovirus 4 & 7
Business address
400 Interpace Pkwy
Parsippany, New Jersey, 07054-1120
US
Notice type
Request for Supply Arrangement
Language(s)
English
,
French
Selection criteria
Not applicable

View the full contract history for Teva Pharmaceuticals USA, Inc..

Contract duration

The contract will be for a period of 40 month(s), from 2020/05/20 to 2023/10/06.

Commodity - UNSPSC

  • 51000000 - Drugs and Pharmaceutical Products

Trade agreements

  • Canadian Free Trade Agreement (CFTA)

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • Exclusive Rights
Contact information

Contracting organization

Organization
Department of Public Works and Government Services (PSPC)
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Contracting authority
Chan, Lina (SPAC/PSPC) (elle-la / she-her)
Email
lina.chan@tpsgc-pwgsc.gc.ca
Date modified: